Category: Infection
WHO: Monkeypox may be airborne
In its latest Monkeypox update, the World Health Organisation’s has declared, for the first time, that Monkeypox may be airborne. More...
Portugal: 20% of all Covid-19 pandemic infections have occurred since BA.5 was first reported
The almost 990,000 confirmed cases in April and May 2022 represent 21% of infections since the beginning of the Covid-19 pandemic, while the 1,455 deaths constitute about 6% of total deaths. More...
Preprint: Long-term mortality following SARS-CoV-2 infection
People infected with SARS-COV-2 had more than three times the risk of dying over the following year compared with those who remained uninfected. More...
Germany: First child to be infected with Monkeypox reported in Berlin
Berlin: The number of infections with monkeypox in Germany continues to rise. More...
CDC: At least two distinct monkeypox outbreaks underway
The US CDC has said that new genetic sequencing data indicate there are at least two distinct monkeypox outbreaks underway outside Africa. More...
SARS-CoV-2 Infection and Persistence Throughout the Human Body and Brain
A video presentation of the recent study entitled “SARS-CoV-2 Infection and Persistence Throughout the Human Body and Brain”. More...
Dr. John Campbell: Wuhan Institute of Virology were working on Monkeypox virus in February 2022
Dr John Campbell wonders why the Wuhan Institute of Virolgy were researching the Monkeypox virus just weeks before the outbreak of Monkeypox in Europe. More...
SARS-CoV-2 can infect and kill different immunity cell types independently of ACE2
In one of the most disturbing preprints we have seen during the entire pandemic, researchers outline the damage that SARS-CoV-2 can do to key components of the human immune system, independently of ACE2. More...
WHO: We don’t know if it’s too late to contain Monkeypox
“We don’t really know whether it is too late to contain Monkeypox”
The fact that this virus has appeared in Europe in a large number of cases, an increasing number of cases, is clearly cause for some concern and it does suggest that there may have been undetected transmission for a while. More...
FDA on Paxlovid rebound: “there is no evidence of benefit at this time for a longer course of treatment”
The US FDA have issued a thinly veiled rebuke to Pfizer CEO Albert Bourla, after his recent comments to Bloomberg News about Covid-19 infections rebounding after treatment with Paxlovid. More...